Key Market Indicators
Sales of antidepressant medication in Greece are projected to decline to roughly $65 million by 2028 from approximately $90 million in 2023, representing an average annual decrease of 4.6%. This marks a continued downward trend, as the Greek market has seen a yearly drop of 6.5% since 2003. In 2023, Greece ranked seventh in the global market for antidepressant sales, with Belgium leading the way at nearly $90 million. Spain, Italy, and Australia followed in the second, third, and fourth positions, respectively.
